Litcius/Paper detail

The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis

Yangjiong Xiao, Yang Yu, Pengcheng Jiang, Yuhong Li, Chao Wang, Rong Zhang

2020Cellular Oncology37 citationsDOIOpen Access PDF

Topics & Concepts

PI3K/AKT/mTOR pathwayOvarian cancerCancer researchProtein kinase BPaclitaxelMetastasisCell growthCarcinogenesisIn vivoCancerMedicineRPTORPharmacologyChemistryBiologyInternal medicineSignal transductionCell biologyBiochemistryBiotechnologyPI3K/AKT/mTOR signaling in cancerPARP inhibition in cancer therapyFOXO transcription factor regulation
The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis | Litcius